The burgeoning field of obesity management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These groundbreaking therapies represent a https://susanawzv980061.azzablog.com/39094275/glp-3-receptor-agonists-retatrutide-trizepatide